Helix, a population-genomics company in the Bay Area, is deep in the viral variant tracking game. With the CDC, Helix identified the spread of variant Alpha — now the most dominant strain in the US.

SAN DIEGO, July 13, 2020 /PRNewswire/ -- Helix, the leading population genomics company, today announced a partnership with San Diego County to make COVID-19 testing accessible across the County to ...

Helix, a direct-to-consumer genomics company, launched the first online marketplace to offer customers personalized products based on genetic testing. The Helix marketplace comprises more than 20 ...

As millions of K-12 students return to in-person learning, school districts across the country have looked to pooled testing as a cost-effective means of monitoring the deadly virus. The method – ...

Marc Laurent gives a tour of a sprawling set of labs that Helix just opened in San Diego’s Sorrento Valley. There’s a row of white sample testing machines that takes Laurent back to the COVID-19 ...

While many makers of COVID-19 diagnostics have reeled in their once-lofty projections for test sales this year—thanks to the widespread and growing availability of the coronavirus vaccines—Helix, for ...

Personal genomics startup Helix, which is developing a digital hub for all things related to DNA testing ranging from direct-to-consumer to doctor-ordered, has announced several partnerships: the ...

23andMe in June started trading after going public in a deal that valued the company at $3.5 billion. Despite 23andMe's success, the consumer genomics market has largely bottomed out, an analyst said.

SOUTH SAN FRANCISCO, Calif., Jan. 26, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health ...

The U.S. National Institutes of Health (NIH) is revealing the first beneficiaries of its Rapid Acceleration of Diagnostics (RADx) program, and San Mateo-based Helix is on the receiving end of $33 ...